Date: August 16, 2022
Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CEST)
Combining our rich experience in molecular biology and cell system engineering, GenScript has established the TurboCHO™ High Performance (HP) platform to enable kilogram level production within a short timeframe. We could reach the typical titer for mAbs up to 3.1 g/L and accept a range of purified antibody products (e.g., IgGs, Fab, scFv, VHH, bi-specific antibodies, and more) in quantities. This newly upgraded production could support various applications, including functional, structural, and therapeutic studies. In addition, the high performance projects will rely on the same expression system for the best consistency and minimal surprises during downstream steps, strengthening the flow of drugs into clinical evaluation with an effective mitigation strategy through gram levels of protein and antibody production. In this webinar, we will introduce how GenScript TurboCHO-HP can assist and support in your diagnostic and antibody drug discovery development.
- Discuss the importance of protein expression in antibody drug discovery development.
- Learn the progress of CHO cell line development.
- GenScript TurboCHO platform provides protein/antibody expression services for antibody drug discovery solutions.
Webinars will be available for unlimited on-demand viewing after live event.